CoreAge Rx advertises a sermorelin starting rate of $99 per month. Invigor Medical publishes sermorelin research discussion and patient-help information, but those pages did not establish a complete current treatment quote for this review. The information available from the two services therefore answers different purchasing questions.

CoreAge Rx receives featured commercial placement on this site. We checked public information on September 20, 2026, without purchasing treatment or testing either preparation. This is a comparison of published offers and care questions, not a clinical ranking of the two providers.

The considered take

Get a current Invigor quote and confirm both services’ care terms. A research article can explain an offering without establishing current price, availability, or clinical superiority.

A published article is not a current order quote

Invigor's educational material discusses sermorelin and links the topic to its service. That establishes published provider information, not the exact preparation, stock, state access, or price a patient would receive today. Ask the service directly for those details.

For CoreAge Rx, confirm the term and inclusions associated with its starting figure rather than treating that number as a verified total. Use the same period of care, with separate entries for clinical visits, tests, medication, supplies, and shipping. The cost guide helps keep missing information visible instead of filling it with an estimate from an old page.

Sources: Invigor Medical: Sermorelin studies and offering · CoreAge Rx: Sermorelin product page

Read study summaries with the exact intervention in view

A provider's explanation of studies can be helpful, but its conclusions should remain attached to the drug and outcome actually tested. Trials involving GHRH-related agents may use tesamorelin or another molecule, and changes in a laboratory marker do not establish every advertised patient benefit.

Apply that standard to both providers. The clinical-studies guide follows selected examples, while the benefits article distinguishes body-composition measurements from strength, function, or long-term wellbeing. Neither educational writing nor a sales-page claim substitutes for evidence about a finished prescription.

Sources: Invigor Medical: Sermorelin studies and offering · Baker et al.: GHRH and cognitive function, controlled trial (2012) · Endotext: Growth Hormone and Aging

Use patient FAQs to prepare, then obtain your own instructions

Invigor's help material can supply questions about use and follow-up. It should not be treated as the prescription for a reader whose product, concentration, and health history have not been assessed. Ask the clinician and pharmacy to resolve the actual instructions in writing.

Do the same if choosing CoreAge Rx. Confirm the pharmacy, ingredients, concentration, route, and storage requirements. The vial-label guide explains why a website regimen or an old syringe marking cannot safely stand in for the directions on a new preparation.

Sources: Invigor Medical: Sermorelin FAQs · CoreAge Rx: Sermorelin product page · Mayo Clinic: Sermorelin injection information

Compare access to reassessment after the initial visit

Ask each service how symptoms, relevant laboratory results, and the original treatment goal are reviewed. Clarify who handles an unexpected reaction and whether a refill requires clinical reassessment. Account support and medical advice should be easy to distinguish.

The Invigor Medical review and CoreAge Rx review collect the broader questions. Obtain written answers before choosing a recurring plan, and ask what happens if treatment does not provide meaningful benefit. This review did not test either service's clinical response, delivery performance, or medication quality.

Sources: Invigor Medical: Sermorelin FAQs · FDA: Managing the benefits and risks of medicines · HHS: Telehealth licensing across state lines

Sources behind this article

Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.

  1. Invigor Medical: Sermorelin studies and offeringProvider educational and commercial page · Public article advertises treatment; current checkout and total costs were not tested.
  2. CoreAge Rx: Sermorelin product pageProvider primary source · Live product page; starting price is not a verified checkout total.
  3. Baker et al.: GHRH and cognitive function, controlled trial (2012)Human randomized controlled study · 152 enrolled adults; 20 weeks of tesamorelin, not sermorelin. Cognitive outcomes are not dementia prevention.
  4. Endotext: Growth Hormone and AgingExpert clinical evidence review · Separates hormone and body-composition findings from functional outcomes and long-term unknowns.
  5. Invigor Medical: Sermorelin FAQsProvider help center · Some broad outcome claims go beyond what the evidence establishes.
  6. Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
  7. FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
  8. HHS: Telehealth licensing across state linesUS government guidance · Licensure options depend on the patient location and state rules.